Mi A Park

Towards a universal ovarian cancer biomarker model: clinical validation of Trx1 and CA125 dual strategy

Abstract Background Ovarian cancer is the fifth leading cause of cancer-related mortality in women, with early detection being critical for improving patient outcomes. Current diagnostic biomarkers, including Cancer antigen 125 (CA125), human epididymis protein 4 (HE4), and their...